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Diagnosed Type 2 Diabetes in Middle-Aged Irish Adults
Jennifer M. O Connor, Sea´n R. Millar*, Claire M. Buckley, Patricia M. Kearney, Ivan J. Perry
Department of Epidemiology & Public Health, University College Cork, Cork, Ireland
Abstract
Background: The prevalence of type 2 diabetes within the Republic of Ireland is poorly defined, although a recent report
suggested 135,000 cases in adults aged 45+, with approximately one-third of these undiagnosed. This study aims to assess
the prevalence of undiagnosed and diagnosed diabetes in middle-aged adults, and compare features related to either
condition, in order to investigate why certain individuals remain undetected.
Methods: This was a cross-sectional study involving a sample of 2,047 men and women, aged between 50–69 years,
randomly selected from a large primary care centre. Univariate logistic regression was used to explore socio-economic,
metabolic and other health related variable associations with undiagnosed or diagnosed diabetes. A final multivariate
analysis was used to determine odds ratios and 95% confidence intervals for having undiagnosed compared to diagnosed
diabetes, adjusted for gender, age and significant covariates determined from univariate models.
Principle Findings: The total prevalence of diabetes was 8.5% (95% CI: 7.4%–8.8%); 72 subjects (3.5%) had undiagnosed
diabetes (95% CI: 2.8%–4.4%) and 102 subjects (5.0%) had diagnosed diabetes (95% CI: 4.1%–6.0%). Obesity, dyslipidaemia,
and family history of diabetes were positively associated with both undiagnosed and diagnosed type 2 diabetes. Compared
with diagnosed subjects, study participants with undiagnosed diabetes were significantly more likely to have low levels of
physical activity and were less likely to be on treatment for diabetes-related conditions or to have private medical insurance.
Conclusions: The prevalence of diabetes within the Cork and Kerry Diabetes and Heart Disease Study is comparable to
recent estimates from the Sla´n National Health and Lifestyle Survey, a study which was nationally representative of the
general population. A considerable proportion of diabetes cases were undiagnosed (41%), emphasising the need for more
effective detection strategies and equitable access to primary healthcare.
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Introduction
Type 2 Diabetes mellitus (T2DM), a chronic disease which
causes significant morbidity and mortality, was the ninth leading
cause of death worldwide in 2008 [1]. Diabetes is associated with
obesity, dyslipidaemia and hypertension, and is characterised by
chronic hyperglycaemia due to insufficient insulin release,
impaired insulin action, or a combination of both [2]. Importantly,
the persistent hyperglycaemia that is associated with diabetes may
cause serious health complications such as cardiovascular disease
(CVD) and impairment and malfunction of the renal, ophthalmic,
vascular and nervous systems. These complications pose significant
financial burdens on healthcare services; research conducted in
2006, which examined economic consequences related to T2DM,
estimated that almost 10% of total health expenditure was spent
on diabetes care in the Republic of Ireland (ROI) alone [3].
The prevalence of T2DM is increasing globally, representing a
key public health issue [4]. There is a lack of research relating to
diabetes in Ireland, although recent studies have indicated that the
condition may be reaching epidemic proportions [5,6]. In 1998,
the prevalence of T2DM amongst subjects in a primary care based
sample was estimated to be 3.9% [7]. A recent report from the
Irish Institute of Public Health (IPH) [8] based on findings from
the 2007 Sla´n National Health and Lifestyle Survey [9], suggested
a prevalence of 8.9% in adults aged 45+. This estimate consisted of
94,000 subjects who had clinically diagnosed T2DM and 41,000
with undiagnosed diabetes. While the efficacy and cost-effective-
ness of routine screening for diabetes in primary care has not been
established [10–12], there is an ongoing need for contemporary
data on the prevalence of T2DM, in population and primary care
settings, in order to guide policy in this area. This could help
formulate strategies that further develop effective diabetes
prevention, detection and management, as individuals with
undiagnosed T2DM are at high risk of diabetic complications
[13].
The aim of this study was to estimate the prevalence of both
undiagnosed and diagnosed T2DM in a sample of men and
women aged 50–69 years, drawn from a primary care setting
similar to that studied in 1998 [7], using the same field survey
procedures and methods. In particular, we determined the extent
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to which the probability of T2DM diagnosis is influenced by access
to primary care as defined by health insurance status.
Methods
Study population
This research makes use of data from the Cork and Kerry
Diabetes and Heart Disease Study (Phase II), a single centre, cross-
sectional study conducted between 2010 and 2011. A population
representative random sample was recruited from a large primary
care centre in Mitchelstown, County Cork, Ireland. The
Livinghealth Clinic includes eight General Practitioners (GP)
and serves a population of approximately 20,000, with a mix of
urban and rural residents. The name, address, gender and date of
birth were provided for all registered attending patients and
stratified random sampling by age and sex was employed to recruit
equal numbers of men and women in four quartiles between the
ages of 50 and 69 years. In total, 3,807 potential participants were
selected from the practice list. Following the exclusion of
duplicates, deaths, and subjects incapable of consenting or
attending appointment, 3,051 were invited to participate in the
study and of these, 2,047 (49.2% male) completed the question-
naire and physical examination components of the baseline
assessment (response rate: 67.1%). The status of non-responders
included individuals refusing to participate (59.4%) and those who
did not reply (40.6%). Male subjects accounted for 53.7% of non-
responders while 43.5% (vs. 42.8% of responders) were .60 years
of age. All non-responders were followed up with a phone call
where possible and otherwise with a single postal reminder. Details
regarding the study design, sampling procedures and methods of
data collection have been reported previously [14].
Ethics committee approval conforming to the Declaration of
Helsinki was obtained from the Clinical Research Ethics
Committee of University College Cork. A letter signed by the
contact GP in the clinic was sent out to all selected participants
with a reply slip indicating acceptance or refusal. All subjects gave
signed informed consent, including permission to use their data for
research purposes.
Clinical and laboratory measurements
The weight and height of each subject were measured to the
nearest 0.1 kg and 0.1 cm respectively by trained researchers.
Study participants were asked to remove heavy outer clothing and
footwear. Portable electronic Tanita WB-100MA weighing scales
(Tanita Corporation, IL, USA) were placed on a firm, flat surface
and were calibrated weekly to ensure accuracy. Height was
measured using a portable Seca Leicester height/length stadi-
ometer (Seca, Birmingham, UK). Two measurements of weight
and height were taken for each subject and the mean value of these
were used in the analysis. Three measurements of systolic and
diastolic blood pressure (SBP and DBP respectively) were obtained
with the subject in a seated position using an Omron M7 digital
sphygmomanometer (Omron Healthcare Co. Ltd., Japan). The
mean of the second and third readings was considered as a
subject’s blood pressure. After an overnight fast, all participants
were invited to attend the clinic for the sampling of blood between
8 and 10 A.M. Triglyceride (TAG), high density lipoprotein
cholesterol (HDL-C) and fasting plasma glucose (FPG) levels were
measured by Cork University Hospital Biochemistry Laboratory
on Olympus biochemistry analysers with Olympus reagents using
standardised procedures and fresh samples (Olympus Diagnostica
Gmbh, Hamburg, Germany). Glucose concentrations were
determined using a glucose hexokinase assay (Olympus Life and
Material Science Europa Ltd., Lismeehan, Co. Clare, Ireland).
Glycated haemoglobin A1c (HbA1c) levels were measured in the
haematology laboratory on an automated high-pressure liquid
chromatography instrument Tosoh G7 (Tosoh HLD-723 (G7),
Tosoh Europe N.V, Tessenderlo, Belgium). A self-administered
General Health Questionnaire (GHQ) was used to collect
supplementary information which included medication use,
demographic characteristics, medical cover, family T2DM history,
past medical history of CVD and smoking and alcohol behaviours.
Physical activity levels were assessed using the validated Interna-
tional Physical Activity Questionnaire (IPAQ) [15].
Metabolic and anthropometric classifications
Metabolic features were categorised according to International
Diabetes Federation metabolic syndrome (MetS) criteria cut-points
[16]. Abnormal metabolic risks were defined as FPG $5.6 mmol/
L, TAG $1.7 mmol/L and HDL-C ,1.03 mmol/L in males and
HDL-C ,1.29 mmol/L in females. Dyslipidaemia was deter-
mined according to elevated TAG and low HDL-C levels.
Hypertension was defined as SBP $140 mmHg) and/or DBP
$90 mmHg [17]. Body Mass Index (BMI) was calculated by
dividing a subject’s weight by the square of their height and was
categorised as ,25= Normal-weight, 25–29.9= Overweight, and
$30= Obese [18,19].
Morbidity
Type 2 diabetes was defined as HbA1c $6.5% (N=146).
Undiagnosed diabetes was determined if subjects had positive
HbA1c tests but did not report a medical diagnosis of T2DM or
oral medication use for the condition (N=72). Diagnosed diabetes
was classified according to positive test results and self-reported
doctor diagnosis or diabetes medication use (N=74), or by
diagnosis or medication use alone (N=28, total diagnosed= 102).
The presence of CVD was obtained from the GHQ by asking
study participants if they had been diagnosed with one of the
following seven conditions: Heart Attack (including coronary
thrombosis or myocardial infarction), Heart Failure, Angina, Aortic
Aneurysm, Hardening of the Arteries, Stroke or any other Heart Trouble.
Subjects indicating a diagnosis of any of these disorders were
classified as having CVD.
Covariates
Covariates utilised from the GHQ included gender, age, use of
prescription (Rx) anti-hypertensive and cholesterol-lowering med-
ication, family T2DM or CVD history, education, social class,
medical cover, physical activity levels, smoking status and alcohol
use. Age was included either as a dichotomous (,60/$60 years of
age) or continuous variable in univariate or multivariate regression
models. Education was divided into four categories: Primary,
Secondary, Diploma and Bachelor or Higher. Social class was defined
according to the European Socio-economic Classification System
(ESeC) [20,21], and collapsed into three groups: High Income,
Middle Income and Low Income. The health service variables – Private
Insurance, No Insurance, and means-tested, state-assisted General
Practice Visit Card (GPC) and Full Medical Card (FMC) – were
transformed into a dummy variable: Private Insurance, State Insurance,
No Insurance. Subjects reporting more than one insurance type were
assigned to the higher insurance category. Self-reported physical
activity within the previous six months, measured using the IPAQ
questionnaire [15], was divided into three categories: High,
Moderate and No Physical Exercise. Alcohol use was assessed by
asking study participants how often they consumed alcohol on a
monthly or weekly basis, and was classified as follows: ‘never or
less than once a month’ - Non-drinker, ‘2–4 times monthly’ -
Occasional Drinker, and ‘twice or more weekly’ - Regular Drinker.
Diabetes Prevalence in Middle-Aged Irish Adults
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Subjects were considered current smokers if they smoked cigarettes
during the recruitment phase, had smoked within the last 10 years
or had smoked more than 100 cigarettes in their lifetime, and non-
smokers if they had smoked less than this or had never smoked.
Statistical analysis
The descriptive statistics (mean, median, standard deviation,
inter-quartiles and percentage distribution) of the study population
were examined by diabetes status. Gender differences in T2DM
prevalence were compared using chi-square tests. The relation-
ships between health conditions, health behaviours, health
insurance status and metabolic/socio-economic factors for indi-
viduals with undiagnosed or diagnosed T2DM were explored
through multiple univariate binary logistic regressions. Diagnosed
subjects were excluded from models examining undiagnosed
T2DM, while models investigating associations between features
and diagnosed diabetes excluded undiagnosed cases. Distinctions
between undiagnosed and diagnosed T2DM were explored in
univariate analyses excluding non-diabetic participants.
To further compare feature/morbidity relationships and
strengths of association to either undiagnosed or diagnosed
T2DM, multivariate logistic regressions were performed. To select
independent predictor variables (IPV) to be included in analysis,
IPVs that had a P-value of less than 0.2 in univariate models were
included in stepwise forward and backwards entry elimination
multivariate analysis, with model stability assessed using the
likelihood ratio (LR). Variables indicating a significant relationship
(P,0.05) with either condition were then entered sequentially, by
order of magnitude of the chi-square association, into two
independent logistic regressions, adjusted for gender and age as
a dichotomous (,60/$60) variable. Using the same procedures, a
final multivariate model comparing undiagnosed to diagnosed
T2DM was determined, adjusted for gender and age as a
continuous measure.
The discriminatory properties of specific IPVs indentified in
multivariate analysis were evaluated. Models including these
variables were assessed for their ability to detect undiagnosed or
diagnosed T2DM using the c statistic. The c statistic is identical to
the area under the receiver operating characteristic curve (AUC)
with values ranging from 0.5 (no better than chance) to 1.0
(indicating perfect discrimination) [22].
Primary data analysis was conducted using PASW Statistics
version 18 (SPSS, Chicago, IL, USA) for Windows. Confidence
intervals for prevalence proportions were calculated using the
VasserStats statistical website [23]. For all analyses, a P-value (two-
tailed) of less than 0.05 was considered to indicate statistical
significance. Glycated haemoglobin A1c test results and diagnostic
status information were available for 1,995 (97.5%) and 1,999
(97.7%) subjects respectively. Missing dichotomous predictor data
values were assumed to be negative, while missing continuous data
were assumed to be ignorable and missing at random.
Results
The baseline characteristics of the study population for
participants with undiagnosed, diagnosed and no diabetes are
shown in table 1. The total prevalence of T2DM was 8.5% (95%
CI: 7.4%–8.8%); 102 (5.0%) subjects had diagnosed diabetes (95%
CI: 4.1%–6.0%) and 72 (3.5%) had undiagnosed diabetes (95%
CI: 2.8%–4.4%), representing 41.4% of all diabetes cases. A
significantly greater proportion of male subjects 11.1% (N=112)
had T2DM compared to females 6.0% (N=62, P,0.001), and a
greater proportion of males had both undiagnosed and diagnosed
T2DM. A high proportion of diabetes cases were overweight or
obese, used Rx anti-hypertensive and cholesterol-lowering med-
ications, had a family history of diabetes or previous history of
CVD, finished education at primary level and reported having low
levels of physical activity within the previous six months.
Variations in health insurance were also noted, with a greater
proportion of T2DM subjects having state-assisted healthcare.
In univariate analysis (table S1), overweight and obesity, family
diabetes and CVD history, elevated TAG, low HDL-C and
dyslipidaemia were significantly associated with both undiagnosed
and diagnosed T2DM. Associations between reduced physical
activity levels and T2DM were noticeably strong, with seven-fold
and approximate two-fold increased odds for undiagnosed or
diagnosed T2DM respectively. With regard to health services
related factors, there was a two-fold increased likelihood of
undiagnosed T2DM in patients on treatment for hypertension
versus a five-fold increased odds for diagnosed diabetes. Similarly,
the odds of having undiagnosed T2DM were approximately two-
fold higher in patients on treatment with cholesterol-lowering
therapy versus an approximate four-fold increase for diagnosed
diabetes. The probability of both undiagnosed and diagnosed
T2DM was significantly reduced in patients with private medical
insurance, whilst the odds of having undiagnosed diabetes were
significantly increased in subjects with no medical insurance (OR:
3.0, 95% CI: 1.6–5.6).
Multivariate analysis (table 2) revealed overweight and obesity,
use of cholesterol-lowering medication, family T2DM history and
dyslipidaemia to be associated with both undiagnosed and
diagnosed T2DM. Low level physical activity (OR: 5.8, 95% CI:
2.7–12.5) and health service variables remained significant
determinants of undiagnosed diabetes, with odds that were
approximately two-fold higher in subjects with state-assisted
healthcare and for participants without medical insurance.
Characteristics associated with diagnosed T2DM included CVD
history, Rx anti-hypertensive therapy and alcohol use. In addition,
male subjects were statistically more likely to have diagnosed
diabetes compared to females (OR: 2.5, 95% CI: 1.5–4.1).
Table 3 shows univariate odds ratios for undiagnosed compared
to diagnosed T2DM. Within this sub-sample of diabetes cases,
significant effects were observed for medication use, family T2DM
history, TAG levels and dylipidaemia. Both health insurance and
physical activity IPVs demonstrated strong associations for having
undiagnosed T2DM, with approximate four-fold increased odds in
subjects without healthcare insurance and in those reporting low
levels of physical activity. Individuals with undiagnosed T2DM
were also more likely to have a higher BMI. Overall, metabolic
features were less optimal in undiagnosed cases, and a greater
proportion had uncontrolled hypertension.
Results from multivariate analysis comparing undiagnosed to
diagnosed T2DM are presented in table 4. Significant associations
were noted for BMI (continuous) and physical inactivity.
Undiagnosed participants were significantly less likely to be on
treatment for hypertension or to have a family history of T2DM
relative to subjects with diagnosed diabetes.
Figures S1 and S2 show AUCs for models to discriminate
undiagnosed or diagnosed T2DM (compared to no diabetes).
Models which included both health insurance and physical activity
IPVs showed a higher discriminatory capacity to detect undiag-
nosed T2DM (c: 0.735, 95% CI: 0.668–0.801) compared to
diagnosed T2DM (c: 0.608, 95% CI: 0.544–0.671). A model
including health insurance, physical activity and BMI (continuous)
displayed further improved discrimination, (c: 0.814, 95% CI:
0.758–0.871) for undiagnosed T2DM vs. (c: 0.698, 95% CI:
0.646–0.750) for diagnosed subjects.
Diabetes Prevalence in Middle-Aged Irish Adults
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Table 1. Characteristics of the study population.1
Feature No diabetes Undiagnosed diabetes Diagnosed diabetes
N=1873 (91.5%) N=72 (3.5%) N=102 (5.0%)
Health conditions
Male 893 (47.8) 43 (59.7) 69 (67.6)
Age 59.0 (54.0–64.0) 60.0 (56.3–65.0) 62.0 (57.0–65.0)
Age $60 875 (46.9) 38 (52.8) 65 (63.7)
On Rx for hypertension 486 (26.0) 32 (44.4) 66 (64.7)
On Rx for cholesterol 609 (32.6) 35 (48.6) 67 (65.7)
BMI (kg/m2) 28.2964.6 33.0666.3 31.1964.4
BMI category:
,25 439 (23.6) 4 (5.6) 2 (2.0)
25–29.9 857 (46.0) 24 (33.3) 43 (42.2)
$30 566 (30.4) 44 (61.1) 57 (55.9)
Family history of T2DM 315 (16.9) 21 (29.2) 54 (52.9)
CVD 167 (8.9) 16 (22.2) 29 (28.4)
Socio-economic
Education:
Bachelor or higher 175 (10.0) 4 (5.9) 5 (5.3)
Diploma 239 (13.7) 6 (8.8) 6 (6.3)
Secondary 863 (49.5) 31 (45.6) 40 (42.1)
Primary only 466 (26.7) 27 (39.7) 44 (46.3)
Social class:
High income 244 (18.2) 6 (11.5) 11 (13.3)
Middle income 396 (29.5) 18 (34.6) 25 (30.1)
Low income 704 (52.4) 28 (53.8) 47 (56.6)
Medical cover
Health insurance:
Private insurance 1196 (64.0) 27 (37.5) 51 (50.0)
State insurance 437 (23.4) 29 (40.3) 44 (43.1)
No insurance 236 (12.6) 16 (22.2) 7 (6.9)
Health behaviours
Physical activity:
High 795 (48.4) 10 (17.5) 31 (34.8)
Moderate 536 (32.6) 19 (33.3) 35 (39.3)
No physical exercise 313 (19.0) 28 (49.1) 23 (25.8)
Smoker 889 (47.6) 38 (52.8) 60 (58.8)
Alcohol use:
Non-drinker 800 (44.7) 38 (55.1) 54 (53.5)
Occasional drinker 367 (20.5) 12 (17.4) 27 (26.7)
Regular drinker 623 (34.8) 19 (27.5) 20 (19.8)
Metabolic
FPG (mmol/L) 4.90 (4.6–5.3) 6.60 (5.6–7.5) 7.50 (5.7–9.4)
FPG $5.6 238 (13.1) 58 (80.6) 80 (80.8)
TAG (mmol/L) 1.19 (0.9–1.6) 1.80 (1.3–2.4) 1.36 (1.0–2.0)
TAG$1.7 417 (23.0) 37 (52.9) 36 (37.5)
HDL-C (mmol/L) 1.4860.4 1.2260.3 1.1860.3
HDL-C (non-optimal)2 267 (14.7) 32 (45.7) 45 (45.0)
Dyslipidaemia3 122 (6.7) 24 (34.3) 21 (21.0)
SBP (mmHg) 129.25616.7 134.18619.3 132.94616.4
DBP (mmHg) 80.2069.7 80.12610.9 78.7969.5
Diabetes Prevalence in Middle-Aged Irish Adults
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Discussion
The results from previous research investigating the prevalence
of T2DM within the ROI are conflicting. In 1998 a study
conducted by Perry et al. [7] suggested an overall prevalence of
3.9%, 30% of whom were undiagnosed, whereas research in 2003,
examining T2DM in primary care [24], estimated a population
prevalence of 9.2%, with undiagnosed subjects representing 23.5%
of all cases. The variance between these studies is possibly
explained by the differences in age groups assessed, or by methods
used for diabetes detection. The higher prevalence of undiagnosed
T2DM identified within the present study population may be due
to use of the HbA1c procedure as compared to the FPG test that
was more commonly employed in the ROI before 2010. Research
conducted in Germany and the United States (US), which
compared FPG and Oral Glucose Tolerance Test methods,
reported that overall prevalence of T2DM would have been lower
had diabetes been classified by FPG [25,26]. The present study
also observed that 14 (19%) undiagnosed subjects (who were
positively identified according to HbA1c concentrations) had FPG
levels that were less than 5.6 mmol/L, and would have been
classified as non-diabetic if this method had been used for
diagnostic purposes within the Cork and Kerry Study. This finding
is consistent with other studies which have reported variations
between HbA1c and FPG [27–29]. Although a recent report from
the US implied that use of the HbA1c assay would not significantly
alter T2DM prevalence and that diabetes categorisation would
remain unchanged in 97.7% of subjects [30], evidence is still
equivocal [31]. Several studies have shown poor concordance
between HbA1c and FPG [27], in particular regarding pre-
diabetes classification [32–34]. Additionally, factors such as age or
ethnicity are thought to influence results [27,28,35]. Nevertheless,
as discussed by Bonora et al., comparisons between diagnostic
methods for T2DM detection are ambiguous, as a true gold
standard test is unavailable [36].
The recent Irish IPH report [8], based on the nationally
representative 2007 Sla´n National Health and Lifestyle Survey [9]
(which also used the HbA1c test), estimated the prevalence of
T2DM in adults 45+ to be 8.9%, which is similar to the result
suggested by this study. In the IPH report, undiagnosed diabetes
prevalence was determined to be 2.7% (30% of all diabetes cases).
Of note, however, is that the IPH research estimated the
prevalence of both undiagnosed and diagnosed T2DM in adults
aged between 55–64 to be 4.6% and 6.3% respectively, which are
comparable to outcomes attained from this study population (3.6%
and 5.6%), for the same age group. Also of interest, is that results
from the Sla´n data are consistent with the present study’s finding
that the prevalence of T2DM in middle-aged subjects within the
ROI is higher in men. Although this gender disparity may be a
consequence of selection bias due to non-response, similarity in
outcomes between the 2007 Sla´n survey and the Cork and Kerry
Diabetes and Heart Disease Study imply that observed prevalence
estimates are valid. It is possible that the lower prevalence of
T2DM in women may be as a result of random opportunistic
screening due to higher GP consultation rates observed in females
[37]. An alternative explanation may be the higher prevalence of
overweight and obesity observed in male subjects within this
population (males: 85.8% vs. females: 70.6%, P for difference
,0.001), a relationship noted in previous research examining
obesity within Ireland [37,38].
As numerous studies have indicated, non-optimal metabolic risk
factors such as elevated TAG and low HDL-C were significantly
and positively associated with both undiagnosed and diagnosed
T2DM [25,26,39]. A noticeable feature of undiagnosed subjects
was the higher percentage of cases with uncontrolled hypertension,
increased TAG concentrations and dyslipidaemia, perhaps
reflecting access to treatment, as a greater proportion of diagnosed
subjects used Rx anti-hypertensive and cholesterol-lowering
medications. Undiagnosed individuals were also less likely to have
a family history of T2DM and CVD, or to engage in regular
physical activity compared to diagnosed subjects. Nevertheless,
unfavourable lipid profiles, T2DM history, low level physical
activity and CVD were all positively associated with both
undiagnosed and diagnosed diabetes. The inverse association
between diagnosed T2DM and alcohol intake was also of interest
as correlations between alcohol use and MetS have been reported
previously [40]. Markedly, 96.6% (N=168) of study participants
with both undiagnosed and diagnosed T2DM were either
overweight or obese, confirming results from previous research
which suggests that obesity is a primary and significant risk factor
related to diabetes development [41]. Screening for T2DM may
be more efficient within these subgroups, particularly individuals
with a combination of these features.
Within the ROI, residents accessing public healthcare are
divided into two categories: (1) those who hold a medical card
(either a FMC or GPC) and thus qualify for means-tested, state-
assisted healthcare insurance. A FMC entitles individuals to free
GP services, Rx medications, public hospital services, dental,
optical and aural services, community care and personal social
services. A GPC entitles individuals to free GP care; (2) non-card
holders, who are entitled to free public hospital services but who
must pay for GP care and may also have to pay in-patient and out-
patient hospital charges. In addition to the public health system
there is also a large private healthcare market [42]. Results from
the present study suggest that within this population, subjects with
private medical insurance are less likely to have undiagnosed or
diagnosed diabetes. This may indicate that these individuals have
greater financial resources and access to screening and healthcare,
or an increased awareness of risk factors related to T2DM. This
awareness could be due to higher educational levels, as it was also
Table 1. Cont.
Feature No diabetes Undiagnosed diabetes Diagnosed diabetes
N=1873 (91.5%) N=72 (3.5%) N=102 (5.0%)
Hypertension4 552 (29.7) 28 (39.4) 28 (27.5)
1Mean and 6 SD are shown for continuous and % are shown for categorical variables. Age, FPG and TAG are shown as a median (interquartile range). Numbers and %
(in brackets) for categorical variables will vary in different analyses as some variables have missing values.
2HDL-C: ,1.03 (MALES) ,1.29 (FEMALES).
3Dyslipidaemia: TAG$1.7 and HDL-C: ,1.03 (MALES) ,1.29 (FEMALES).
4Hypertension: SBP$140 and/or DBP$90.
doi:10.1371/journal.pone.0080504.t001
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noted that study participants who had only completed education
to a primary level were more likely to have diabetes. Although
social class (defined by the ESeC) was not an associated risk factor
for having either undiagnosed or diagnosed T2DM, it is possible
that the lower prevalence of diabetes amongst subjects with private
medical insurance was due to socio-economic inequalities, as study
participants in receipt of state-assisted medical insurance were
notably at a higher risk. These findings suggest that diabetes cases
occur disproportionately amongst individuals who are economi-
cally deprived and have lower education levels, and this concurs
with previous research which found significant correlations
between social deprivation and T2DM [43].
Importantly, these results also imply that health service
inequalities are significant determinants of diagnostic status, as a
greater proportion of undiagnosed cases indicated having no state-
assisted or private healthcare insurance. This is consistent with
outcomes observed in previous studies which have examined
relationships between healthcare inequities and T2DM [13,44].
Univariate analysis suggested three-fold and four-fold increased
odds of having undiagnosed T2DM in subjects without medical
insurance when compared to individuals with no diabetes (table
S1) or diagnosed T2DM (table 3) respectively. This association was
also noted in a multivariate logistic regression comparing
undiagnosed to non-diabetic individuals (table 2) but was not
observed in multivariate analysis restricted to subjects with T2DM
(table 4).
To investigate this discrepancy, we forced the health insurance
IPV into a model and entered covariates independently to assess
confounder-adjusted relationships. In a logistic regression which
controlled for family T2DM history, Rx anti-hypertensives, BMI,
age and gender, having no healthcare insurance remained strongly
associated with undiagnosed T2DM (OR: 3.5, 95% CI: 1.2–10.4,
P= 0.025) although this was attenuated when the physical activity
IPV was included (OR: 2.4, 95% CI: 0.7–8.9, P= 0.184). This
may indicate a relationship between physical activity and both
health insurance and undiagnosed T2DM or that physical activity
levels explain most of the variance. Equally possible is that missing
data from the IPAQ questionnaire resulted in a loss of statistical
power.
We further explored health insurance/physical activity rela-
tionships with undiagnosed/diagnosed T2DM using the LR. Tests
for model assessment included significant covariates, age, gender
and either health insurance or physical activity IPVs. Both models
implied similar goodness of fit (LR chi-square: 33.29, P,0.001 for
a model with health insurance vs. LR chi-square: 32.68, P,0.001
for a model with physical activity) in full models against a constant,
indicating that both predictors may be clinically relevant. In
addition, it was noted that models including health insurance and
physical activity IPVs displayed variations in discriminatory ability
to detect either undiagnosed or diagnosed T2DM (figures S1 and
S2). This suggests that use of these variables in T2DM risk
prediction scores may be useful for identifying a subset of diabetes
cases.
Strengths and limitations
As one of the largest cross-sectional studies performed to date
within the ROI, the Cork and Kerry Diabetes and Heart Disease
Study sample size is comparable to other related Irish studies.
Selection bias was minimised as a similar number of male and
female subjects, aged between 50–69 years of age, were randomly
selected from a register of patients within a single primary care
based sample. Furthermore, non-responders had similar numbers
for both males and females and likewise for age groups. Few
studies have assessed the prevalence of undiagnosed or diagnosed
T2DM within one broadly representative population sample or
compared features between undiagnosed and diagnosed subjects.
Finally, use of the HbA1c measurement provided prevalence rates
Table 2. Odds ratios (95% CI) of having undiagnosed or
diagnosed type 2 diabetes compared to no diabetes –
multivariate logistic regression adjusted for gender, age and
all significant covariates.
Feature Odds ratio 95% CI
Undiagnosed T2DM compared to no
diabetes1
Male 1.4 (0.8–2.5)
Age$60 1.0 (0.6–1.9)
On Rx for cholesterol 2.2 (1.2–3.9)
BMI category:
,25 1
25-29.9 4.5 (1.0–19.5)
$30 6.8 (1.6–29.4)
Family history of T2DM 1.9 (1.0–3.6)
Health insurance:
Private insurance 1
State insurance 2.2 (1.2–4.2)
No insurance 2.3 (1.0–5.2)
Physical activity:
High 1
Moderate 1.9 (0.8–4.2)
No physical exercise 5.8 (2.7–12.5)
Dyslipidaemia3 4.3 (2.3–8.3)
Diagnosed T2DM compared to no
diabetes2
Male 2.5 (1.5–4.1)
Age$60 1.4 (0.9–2.3)
On Rx for hypertension 2.7 (1.7–4.4)
On Rx for cholesterol 2.0 (1.2–3.3)
BMI category:
,25 1
25–29.9 8.2 (1.9–34.6)
$30 9.4 (2.2–40.3)
Family history of T2DM 5.9 (3.7–9.4)
CVD 2.0 (1.1–3.5)
Alcohol use:
Non-drinker 1
Occasional drinker 1.3 (0.7–2.2)
Regular drinker 0.4 (0.2–0.7)
Dyslipidaemia3 1.9 (1.0–3.5)
1Model excludes subjects with diagnosed T2DM. Final model covariates entered
in order: dyslipidaemia, BMI
category, physical activity, health insurance, on Rx for cholesterol, family history
of T2DM, gender and age.
2Model excludes subjects with undiagnosed T2DM. Final model covariates
entered in order: family history of T2DM,
on Rx for hypertension, BMI category, on Rx for cholesterol, CVD, dyslipidaemia,
alcohol use, gender and age.
3Dyslipidaemia: TAG$1.7 and HDL-C: ,1.03 (MALES) ,1.29 (FEMALES).
doi:10.1371/journal.pone.0080504.t002
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Table 3. Univariate odds ratios (95% CI) of having undiagnosed compared to diagnosed type 2 diabetes.1
Feature Undiagnosed diabetes Diagnosed diabetes Odds ratio 95% CI
N=72 (41.4%) N=102 (58.6%)
Health conditions
Female 29 (40.3) 33 (32.4) 1
Male 43 (59.7) 69 (67.6) 0.7 (0.4–1.3)
Age ,60 years 34 (47.2) 37 (36.3) 1
Age$60 years 38 (52.8) 65 (63.7) 0.6 (0.3–1.2)
Not on Rx for hypertension 40 (55.6) 36 (35.3) 1
On Rx for hypertension 32 (44.4) 66 (64.7) 0.4 (0.2–0.8)
Not on Rx for cholesterol 37 (51.4) 35 (34.3) 1
On Rx for cholesterol 35 (48.6) 67 (65.7) 0.5 (0.3–0.9)
BMI (kg/m2) 33.0666.3 31.1964.4 1.1 (1.0–1.1)
BMI category:
,25 4 (5.6) 2 (2.0) 1
25–29.9 24 (33.3) 43 (42.2) 0.3 (0.1–1.7)
$30 44 (61.1) 57 (55.9) 0.4 (0.1–2.2)
No family history of T2DM 51 (70.8) 48 (47.1) 1
Family history of T2DM 21 (29.2) 54 (52.9) 0.4 (0.2–0.7)
No CVD 56 (77.8 73 (71.6) 1
CVD 16 (22.2) 29 (28.4) 0.7 (0.4–1.5)
Socio-economic
Education:
Bachelor or higher 4 (5.9) 5 (5.3) 1
Diploma 6 (8.8) 6 (6.3) 1.3 (0.2–7.1)
Secondary 31 (45.6) 40 (42.1) 1.0 (0.2–3.9)
Primary only 27 (39.7) 44 (46.3) 0.8 (0.2–3.1)
Social class:
High income 6 (11.5) 11 (13.3) 1
Middle income 18 (34.6) 25 (30.1) 1.3 (0.4–4.2)
Low income 28 (53.8) 47 (56.6) 1.1 (0.4–3.3)
Medical cover
Health insurance:
Private insurance 27 (37.5) 51 (50.0) 1
State insurance 29 (40.3) 44 (43.1) 1.2 (0.6–2.4)
No insurance 16 (22.2) 7 (6.9) 4.3 (1.6–11.8)
Health behaviours
Physical activity:
High 10 (17.5) 31 (34.8) 1
Moderate 19 (33.3) 35 (39.3) 1.7 (0.7–4.2)
No physical exercise 28 (49.1) 23 (25.8) 3.8 (1.5–9.3)
Non-smoker 34 (47.2) 42 (41.2) 1
Smoker 38 (52.8) 60 (58.8) 0.8 (0.4–1.4)
Alcohol use:
Non-drinker 38 (55.1) 54 (53.5) 1
Occasional drinker 12 (17.4) 27 (26.7) 0.6 (0.3–1.4)
Regular drinker 19 (27.5) 20 (19.8) 1.4 (0.6–2.9)
Metabolic
TAG (mmol/L) 1.80 (1.3–2.4) 1.36 (1.0–2.0) 1.5 (1.1–2.0)
TAG ,1.7 33 (47.1) 60 (62.5) 1
TAG$1.7 37 (52.9) 36 (37.5) 1.9 (1.0–3.5)
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comparable to those from a recent nationally representative study:
the 2007 Sla´n National Health and Lifestyle Survey [9].
Notwithstanding these strengths, several limitations can be
identified. The use of self-reported questionnaires is subject to
potential inaccuracies, recall and reporting bias [45,46]. Misclas-
sification of diabetes from self-reporting is a recognised limitation
present in all surveys, and is a particular restraint in the ROI due
to the absence of a unique health identifier within the Irish
healthcare system [47]. This makes linkage with other records,
such as disease registries or death records problematic [14].
Nonetheless, several studies have indicated a reasonable or high
degree of concordance between T2DM prevalence and self-
reporting [45,48–50] and whenever possible empirical methods
were used in analysis. Additionally, within this sample there was a
high level of agreement between self-reported doctor diagnosis of
T2DM and Rx diabetes medication use (Kappa: 0.854, 95% CI:
0.796–0.912, P,0.001).
Equally of concern is that prevalence estimates were derived
from a single primary care based sample which may not be
representative of the general Irish population. However, previous
research suggests that approximately 98% of Irish adults are
registered with a GP and that, even in the absence of a universal
patient registration system, it is possible to perform population
based epidemiological studies that are representative of the general
population using these methods [51]. Further studies are needed to
definitively confirm this conclusion. If correct, it may indicate that
findings from the Cork and Kerry Diabetes and Heart Disease
Study are generalisable to the Irish population aged between 50–
69 years. Also, as this research makes use of cross-sectional data,
interpretations of these findings are compromised by the inability
to infer causal relationships. Nevertheless, the relationships
described have been extensively replicated in other prospective
cohort studies. Finally, with regard to statistical procedures
employed in analysis, the possibility of model over-fitting or type
II errors cannot be discounted, and results should be considered
preliminary and exploratory, as future studies with larger sample
sizes and greater statistical power might find other relationships
[52].
Conclusions
The prevalence of T2DM within the ROI is consistent with
trends worldwide [53,54], and is primarily driven by the increasing
obesity epidemic [4,55]. Despite policies and continued investment
in services which promote awareness and knowledge of a disease
that is largely preventable, the prevalence of diabetes in Ireland is
rising [8].
Socio-economic and health service inequalities are significant
risk factors for having undiagnosed T2DM. The results from this
study indicate that subjects with state-subsidised healthcare
insurance, and those without private or state-assisted medical
cover, are more likely to be undetected. These findings suggest
that individuals from lower socio-economic backgrounds should be
targeted. Observed low levels of physical activity, obesity level
assessment and recognition of untreated cardiovascular conditions
may also improve identification of T2DM cases within clinical
practice. Finally, as a successful programme to detect subjects with
T2DM may depend on regular General Practice attendance, a
Table 3. Cont.
Feature Undiagnosed diabetes Diagnosed diabetes Odds ratio 95% CI
N=72 (41.4%) N=102 (58.6%)
HDL-C (mmol/L) 1.2260.3 1.1860.3 1.7 (0.6–4.7)
Optimal HDL-C 38 (54.3) 55 (55.0) 1
Non-optimal HDL-C2 32 (45.7) 45 (45.0) 1.0 (0.6–1.9)
No dyslipidaemia 46 (65.7) 79 (79.0) 1
Dyslipidaemia3 24 (34.3) 21 (21.0) 2.0 (1.0–3.9)
SBP (mmHg) 134.18619.3 132.94616.4 1.0 (0.99–1.0)
DBP (mmHg) 80.12610.9 78.7969.5 1.0 (0.98–1.0)
No hypertension 43 (60.6) 74 (72.5) 1
Hypertension4 28 (39.4) 28 (27.5) 1.7 (0.9–3.3)
1Mean and 6 SD are shown for continuous variables. TAG is shown as a median (interquartile range). Numbers and % (in brackets) for categorical variables will vary in
different analyses as some variables have missing values.
2HDL-C: ,1.03 (MALES) ,1.29 (FEMALES).
3Dyslipidaemia: TAG$1.7 and HDL-C: ,1.03 (MALES) ,1.29 (FEMALES).
4Hypertension: SBP$140 and/or DBP$90.
doi:10.1371/journal.pone.0080504.t003
Table 4. Odds ratios (95% CI) of having undiagnosed
compared to diagnosed type 2 diabetes – multivariate logistic
regression adjusted for all significant covariates.1
Feature Model 1 Model 2
2
Odds
ratio 95% CI
Odds
ratio 95% CI
BMI (kg/m2) 1.1 (1.0–1.2) 1.1 (1.0–1.2)
On Rx for hypertension 0.3 (0.2–0.7) 0.3 (0.1–0.7)
Family history of T2DM 0.4 (0.2–0.8) 0.4 (0.2–0.8)
Physical activity:
High 1 1
Moderate 1.6 (0.6–4.3) 1.6 (0.6–4.3)
No physical exercise 3.5 (1.3–9.3) 3.4 (1.3–9.1)
1Final model covariates entered in order: family history of T2DM, physical
activity, on Rx for hypertension and BMI.
2Adjusted for gender and age.
doi:10.1371/journal.pone.0080504.t004
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strategic approach which identifies individuals without access to
primary health services and which furthers efforts to promote
affordable and equitable healthcare, is needed to prevent
predictable sequelae for affected individuals and populations.
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